Evidence map›Paper›PMID 38926899›Full record

ArticleGenome biology2024

Resolving intra-repeat variation in medically relevant VNTRs from short-read sequencing data using the cardiovascular risk gene LPA as a model.

Silvia Di Maio, Peter Zöscher, Hansi Weissensteiner, Lukas Forer, Johanna F Schachtl-Riess, Stephan Amstler, Gertraud Streiter, Cathrin Pfurtscheller, Bernhard Paulweber, Florian Kronenberg and 2 more

Abstract read
In one paragraph

Article in Genome biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. KILDA: identifying KIV-2 repeats from kmers.NAR genomics and bioinformatics · 2025
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Silvia Di Maio *Institute of Genetic Epidemiology, Medical University of Innsbruck, Innsbruck, Austria.
Peter Zöscher *Institute of Genetic Epidemiology, Medical University of Innsbruck, Innsbruck, Austria.
Hansi WeissensteinerInstitute of Genetic Epidemiology, Medical University of Innsbruck, Innsbruck, Austria.
Lukas ForerInstitute of Genetic Epidemiology, Medical University of Innsbruck, Innsbruck, Austria.
Johanna F Schachtl-RiessInstitute of Genetic Epidemiology, Medical University of Innsbruck, Innsbruck, Austria.
Stephan AmstlerInstitute of Genetic Epidemiology, Medical University of Innsbruck, Innsbruck, Austria.
Gertraud StreiterInstitute of Genetic Epidemiology, Medical University of Innsbruck, Innsbruck, Austria.
Cathrin PfurtschellerInstitute of Genetic Epidemiology, Medical University of Innsbruck, Innsbruck, Austria.
Bernhard PaulweberDepartment of Internal Medicine I, Paracelsus Medical University/Salzburger Landeskliniken, Salzburg, Austria.
Florian KronenbergInstitute of Genetic Epidemiology, Medical University of Innsbruck, Innsbruck, Austria.
Stefan CoassinInstitute of Genetic Epidemiology, Medical University of Innsbruck, Innsbruck, Austria.
Sebastian SchönherrInstitute of Genetic Epidemiology, Medical University of Innsbruck, Innsbruck, Austria. sebastian.schoenherr@i-med.ac.at.ORCID 0000-0001-5909-9226

Funding

Austrian Science Fund P31458-B34Austrian Science Fund W-1253DK HOROSAustrian Science Fund FWF P 31458European Atherosclerosis Society Research Grant 2018
6 · The paper itself

Abstract

backgroundVariable number tandem repeats (VNTRs) are highly polymorphic DNA regions harboring many potentially disease-causing variants. However, VNTRs often appear unresolved ("dark") in variation databases due to their repetitive nature. One particularly complex and medically relevant VNTR is the KIV-2 VNTR located in the cardiovascular disease gene LPA which encompasses up to 70% of the coding sequence.

resultsUsing the highly complex LPA gene as a model, we develop a computational approach to resolve intra-repeat variation in VNTRs from largely available short-read sequencing data. We apply the approach to six protein-coding VNTRs in 2504 samples from the 1000 Genomes Project and developed an optimized method for the LPA KIV-2 VNTR that discriminates the confounding KIV-2 subtypes upfront. This results in an F1-score improvement of up to 2.1-fold compared to previously published strategies. Finally, we analyze the LPA VNTR in > 199,000 UK Biobank samples, detecting > 700 KIV-2 mutations. This approach successfully reveals new strong Lp(a)-lowering effects for KIV-2 variants, with protective effect against coronary artery disease, and also validated previous findings based on tagging SNPs.

conclusionsOur approach paves the way for reliable variant detection in VNTRs at scale and we show that it is transferable to other dark regions, which will help unlock medical information hidden in VNTRs.

Indexed as

Cardiovascular DiseasesMinisatellite RepeatsGenetic Predisposition to DiseaseGenetic VariationHumansLipoprotein(a)Sequence Analysis, DNALipoprotein(a)Dark genome regionLp(a)Medically relevant geneNextflowUK BiobankVariable number tandem repeatVNTRWhole-exome sequencing

Identifiers

PMID38926899
PMCPMC11201333

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.